Latest Breaking News On - Fibrogen inc - Page 1 : vimarsana.com

FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen s Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO® in Upcoming Clinical Trials

FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen s Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO® in Upcoming Clinical Trials
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

David deluciaDeyaa adibSimon millerGlobenewswire incCorporate communicationsFibrogen incExchange commissionDrug administrationRegeneron pharmaceuticalsChina health authorityChief medical officerInvestigational new drugSupplemental new drug applicationInvestor inquiriesInvestor relationsMedia inquiries

FibroGen Stock Is Surging After The Bell: What s Going On? - FibroGen (NASDAQ:FGEN)

FibroGen shares are moving higher in Monday's after-hours session after the company announced the FDA cleared its Investigational New Drug (IND) FG-3165. The company also announced a new clinical trial supply agreement with Regeneron.

Deyaa adibFibrogen incRegeneron pharmaceuticalsInvestigational new drugThane wettig

William Blair Weighs in on FibroGen, Inc s Q1 2025 Earnings (NASDAQ:FGEN)

William Blair Weighs in on FibroGen, Inc s Q1 2025 Earnings (NASDAQ:FGEN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

William blairMirae asset global investments coFibrogen company profileMackenzie financial corpFibrogen incFree reportGet free reportGen stock downWealth managementFinancial corpMirae asset global investmentsFibrogen daily

FibroGen, Inc to Post Q1 2025 Earnings of $0 00 Per Share, William Blair Forecasts (NASDAQ:FGEN)

FibroGen, Inc to Post Q1 2025 Earnings of $0 00 Per Share, William Blair Forecasts (NASDAQ:FGEN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William blairSecurities exchange commissionFibrogen incArmistice capitalAcadian asset managementPrimecap management coFree reportGen trading downGet free reportExchange commissionAsset managementPennant investorsFibrogen daily

Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Zeta Global Holdings (NYSE:ZETA)

Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - Zeta Global Holdings (NYSE:ZETA)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Zeta global holdings corpAmbac financial group incStrong global entertainment incSymbotic incPalantir technologies incElectronic artsTc biopharm holdings plcFg acquisition corpHoldco nuvo groupdg ltdAgriforce growing systems ltdBiosystems incAudiocodes ltdTrupanion incF international limitedPlutonian acquisition corpHims hers health inc